Director/PDMR Shareholding
October 13 2008 - 9:26AM
UK Regulatory
RNS Number : 7150F
Hikma Pharmaceuticals Plc
13 October 2008
13 October 2008
Hikma Pharmaceuticals PLC (the "Company")
Director Shareholding
Notification of Option Exercise
LONDON, 13 October 2008 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (DIFX: HIK), the multinational pharmaceuticals group, announces
that on 13 October 2008 the following Director exercised his option to purchase the number of ordinary shares of 10 pence each set out in
the table below in the capital of the Company. These options were granted on the date shown below pursuant to the Company's 2004 Stock
Option Plan:
Name Date of Grant Number of Shares Exercised
Samih Darwazah 12 October 2004 320,000
As a result of the above transactions the Director listed below now has the following holdings in the ordinary share capital of the
Company:
Name Ordinary Shares in the Company Percentage of Share capital
Samih Darwazah 2,195,450 1.16%
The issued share capital of Hikma Pharmaceuticals PLC is now 189,142,807 ordinary shares of 10 pence each.
Date of Notification: 13 October 2008
Henry Knowles
Company Secretary
020 7399 2760
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBXBDGSDBGGIX
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024